It is ethical to modify DNA.
In 2018, Chinese scientist He Jiankui announced the birth of two girls whose embryos had been genetically modified using CRISPR. The stated objective was to alter a gene associated with the entry of HIV into human cells. The experiment triggered an international outcry; beyond the serious ethical concerns, there were questions regarding the safety of the modifications and the potential consequences for the girls' development.
An AI can identify thousands of possibilities for genetic modification, yet determining which of them are safe, necessary, or acceptable remains a human responsibility. There is also the question of access: if technologies capable of altering biological traits become a reality, who will be able to use them? Will these treatments be available to everyone, or will they be resources restricted to a small segment of the population? And how can we prevent interventions intended to combat disease from being used to establish patterns of human traits deemed desirable?